Rigaku Launches Sales of the XHEMIS TX-3000, a TXRF Analytical System for Leading-edge Semiconductor Processes
Rigaku Corporation, a global solution partner in X-ray analytical systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has launched sales of the XHEMIS (pronounced “ZEM-mis”) TX-3000, a total reflection X-ray fluorescence (TXRF) system that supports analysis of trace contamination on wafer surfaces in semiconductor manufacturing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826707850/en/
Measurement result of surface contaminant distribution
Rigaku protects the quality with TXRF technology, a field where it holds overwhelming market share
Analysis of trace contaminants on wafer surfaces is vital to semiconductor manufacturing. As production steps become increasingly detailed and quality standards grow ever more stringent, this process plays a significant role in reducing defect rates. Moreover, manufacturing lines that incorporate hundreds of steps require precise analysis of trace contaminants on wafer surfaces to maintain stable operation and the reliability of product quality. With TXRF, a representative approach for this purpose, Rigaku has established its technology as the effective global standard. The Company has long been a driver of rising quality standards in the industry.
Rigaku’s latest model, the XHEMIS TX-3000, improves on existing features to deliver a quantum leap in measurement precision, operability and productivity.
Up to 6× increase in speed enables former one-hour measurement tasks to be completed in 10 minutes
The XHEMIS TX-3000 achieves processing speeds up to 6× that of Rigaku’s previous systems. First, measurement speed is tripled by combining a newly developed optical array with a novel multi-element detector. Next, this combined system is coupled with an AI-driven spectrum forecasting technology to double measurement speed without sacrificing precision. The technical innovation of this two-stage arrangement contributes to improved productivity and process stability at semiconductor manufacturing sites. With our previous model, measurements that took typically one hour, now finish in just 10 minutes.
New detector design supports analysis of lighter elements
The XHEMIS TX-3000 adopts an X-ray source that can be switched among three wavelengths, enabling analysis of lighter elements such as sodium, magnesium and aluminum that are difficult to detect using fluorescent X-ray analytical systems. In this way the surface distribution of contaminants can be measured for virtually all elements without sample destruction.
In addition, the XHEMIS TX-3000 combines a newly developed monochromator capable of X-ray irradiation with a multi-element detector that can measure three locations on the wafer surface simultaneously. By combining these features, the XHEMIS TX-3000 boosts measurement speed by a factor of 3 in comparison with previous systems.
AI supports high precision and expanded applications
One issue with fluorescent X-ray analytical systems is that shortening measurement time tends to degrade measurement precision. To address this issue, the XHEMIS TX-3000 adopts spectrum-forecasting software trained on vast quantities of analysis data. In this way precision is maintained even while cutting measurement time in half.
Additionally, a new feature reduces unnecessary background signal, expanding the range of applications to a wide variety of materials previously unamenable to trace-contamination measurement, such as barrier metals (protective coating for wiring), high-dielectric films, and compound semiconductors.
Kiyoshi Ogata, Senior Executive Vice President, commented as follows:
Rigaku forecasts sales of approximately 5 billion yen for conventional TXRF products in 2025. With the introduction to market of this high-end system, Rigaku expects adoption by major semiconductor manufacturers to advance. The Company expects this product segment to enjoy double-digit growth for successive years as a stable platform supporting sustainable growth in the semiconductor market.
System details
https://rigaku.com/products/semiconductor-metrology/txrf/xhemis-tx-3000?setLang=english
About the Rigaku Group
Since its establishment in 1951, the engineering professionals of the Rigaku group have been dedicated to benefiting society with leading-edge technologies, notably including its core fields of X-ray and thermal analysis. With a market presence in over 90 countries and some 2,000 employees from 9 global operations, Rigaku is a solution partner in industry and research analysis institutes. Our overseas sales ratio has reached approximately 70% while sustaining an exceptionally high market share in Japan. Together with our customers, we continue to develop and grow. As applications expand from semiconductors, electronic materials, batteries, environment, resources, energy, life science to other high-tech fields, Rigaku realizes innovations “To Improve Our World by Powering New Perspectives.”
For details, please visit rigaku-holdings.com/english
View source version on businesswire.com: https://www.businesswire.com/news/home/20250826707850/en/
Contacts
Press Contact:
Sawa Himeno
Head of Communications Dept., Rigaku Holdings Corporation
prad@rigaku.co.jp
Tel: +81 90 6331 9843
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom